International Stem Cell CORP (ISCO) stock
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
International Stem Cell gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
International Stem Cell's gross profit for the twelve months ending Jun 30, 2026 was $5.23M, down 1.7% year over year. For fiscal 2025 it was $5.07M, down 4.8% from the year before. Over ten years it grew -0.8% a year on average. The highest annual figure on record is $7.02M in fiscal 2018.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.07M | -4.8% |
| FY2024 | Dec 31, 2024 | $5.32M | +15.5% |
| FY2023 | Dec 31, 2023 | $4.61M | -6.2% |
| FY2022 | Dec 31, 2022 | $4.91M | +15.8% |
| FY2021 | Dec 31, 2021 | $4.24M | -2.4% |
| FY2020 | Dec 31, 2020 | $4.35M | -21.5% |
| FY2019 | Dec 31, 2019 | $5.54M | -21.1% |
| FY2018 | Dec 31, 2018 | $7.02M | +31.6% |
| FY2017 | Dec 31, 2017 | $5.33M | +2.2% |
| FY2016 | Dec 31, 2016 | $5.22M | -5.0% |
| FY2015 | Dec 31, 2015 | $5.50M | +7.8% |
| FY2014 | Dec 31, 2014 | $5.10M | +13.1% |
| FY2013 | Dec 31, 2013 | $4.50M | +36.7% |
| FY2012 | Dec 31, 2012 | $3.30M | +13.1% |
| FY2011 | Dec 31, 2011 | $2.91M | +245.7% |
| FY2010 | Dec 31, 2010 | $843.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.46M | -4.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.36M | +19.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.09M | -25.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.32M | +9.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.52M | +7.2% |
| Q1 FY2025 | Mar 31, 2025 | $1.14M | -8.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.46M | +41.9% |
| Q3 FY2024 | Sep 30, 2024 | $1.21M | +1.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.42M | +25.7% |
| Q1 FY2024 | Mar 31, 2024 | $1.24M | -1.6% |
| Q4 FY2023 | Dec 31, 2023 | $1.03M | -20.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.19M | +17.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.13M | -13.8% |
| Q1 FY2023 | Mar 31, 2023 | $1.26M | -2.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.29M | +21.7% |
| Q3 FY2022 | Sep 30, 2022 | $1.01M | -2.9% |
| Q2 FY2022 | Jun 30, 2022 | $1.31M | +57.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.30M | +41.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.06M | -2.7% |
| Q1 FY2021 | Mar 31, 2021 | $1.04M | -30.6% |
| Q4 FY2020 | Dec 31, 2020 | $833.00K | -40.5% |
| Q3 FY2020 | Sep 30, 2020 | $918.00K | -29.2% |
| Q2 FY2020 | Jun 30, 2020 | $1.09M | -25.3% |
| Q1 FY2020 | Mar 31, 2020 | $1.50M | +9.2% |
| Q4 FY2019 | Dec 31, 2019 | $1.40M | +0.9% |
| Q3 FY2019 | Sep 30, 2019 | $1.30M | -31.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.46M | -24.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.38M | -23.8% |
| Q4 FY2018 | Dec 31, 2018 | $1.39M | +14.0% |
| Q3 FY2018 | Sep 30, 2018 | $1.88M | +36.9% |
| Q2 FY2018 | Jun 30, 2018 | $1.94M | +50.5% |
| Q1 FY2018 | Mar 31, 2018 | $1.81M | +24.5% |
| Q4 FY2017 | Dec 31, 2017 | $1.22M | -1.4% |
| Q3 FY2017 | Sep 30, 2017 | $1.37M | +2.7% |
| Q2 FY2017 | Jun 30, 2017 | $1.29M | -8.4% |
| Q1 FY2017 | Mar 31, 2017 | $1.45M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.24M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.34M | – |
| Q2 FY2016 | Jun 30, 2016 | $1.41M | – |
See a number that looks wrong?